Abstract
Years ago, it was thought that a genetic component was the fundamental cause of a number retinopathy diseases including age related macular degeneration (AMD). Since then, information has emerged about novel genes that contribute to various forms of AMD and other retinopathies that have been eluding researchers for years. In the genetic sense, only the APOE 2 and 4 genes have been found to be a risk factor for sporadic AMD. But, a recent Genome wide association study (GWAS) revealed that an alteration of five SNIPs on the X chromosome in a gene named DIAPH2 may be a susceptibility gene for AMD. Furthermore, the gene DIAPH2 showed to have a polygenic pleiotropy for premature ovarian failure (POF) and AMD in a cohort of women. POF is highly associated with X chromosome skewing, an epigenetic alteration of the inactivation process of the X chromosome. These findings suggest a hypothesis that an epigenetic alteration on the inactivation centres of the X chromosome (or skewing) relates not only to aging, but might be a novel property that affects women with AMD more often than men.
Key Words: X Chromosome, AMD, DIAPH2 Gene, X Chromosome Skewing
INTRODUCTION
The human X chromosome is unique and its uniqueness is based on the fact that 5% of the human genome is concentrated on the X chromosome and that the duplication of this genetic material in women demands systematic compensation of the gene dosage in order to silence one the copy of the X chromosome [1] . Age Related Macular degeneration (AMD) is the most prevalent form of retinopathy in the elderly. Furthermore, there is a slight prevalence of female susceptibility to AMD [2,3] suggesting the involvement of the X chromosome. In AMD, the X chromosome is not prevalent in comparison to other chromosomes [4] but as we shall encounter, a possible role in epigenetic control of X chromosome inactivation might be considered as a novel pathway in AMD pathogenesis.
Two basic forms of AMD have been the focus of research [4-6]. Central geographic atrophy is referred to the "dry" form of advanced AMD. This form results from atrophy of the retinal pigment epithelial layer below the retina, which causes vision loss through loss of photoreceptors (rods and cones) in the central part of the eye. The other form is names "wet" or neovascular/exudative AMD which is related to abnormal vessel growth in the choriocapillaris through the Bruch’s membrane, leading to a leakage of protein and blood in the macula [5-6]. These two forms account for almost 2 million people in the US alone and seven million people at risk [6]. With today’s increased life expectancy, this devastating disease will continue to have a significant public health impact on the quality of life worldwide [6]. Epidemiological studies provide a conclusion of a strong interplay of epigenetic, genetic and environmental factors in AMD pathogenesis [7]. At present, aging [7,8], chronic oxidative stress [9], inflammation [10], vascular disease [11], UV exposure [12], nutritional status [13], altered fatty acid metabolism [14], are strongly linked to AMD [15] suggesting that AMD etiology is known to be multifactorial, i.e., in addition to a strong genetic component. Still, advanced age and family history are the two major risk factors [16]. To understand AMD in the context of aging we will address the X chromosome not to its genetic alterations but its unique epigenetic properties to manifest inactivation of one of its X chromosomes in women and also its relation to skewing which may also affect male subjects [17].
X linked genetics in retinopathies and AMD
The X chromosome harbors a number of disease loci that affect the retina, including cone dystrophy (COD1 and COD2), juvenile retinoschisis (XLRS), congenital stationary night blindness (CSNB), and at least five loci for retinitis pigmentosa (Table 1, ref [18, 19-35]). Still, a number of gens have been cloned and mapped that of macular degeneration, but not for the X chromosome, except some deletions in green and red color genes at Xq28 (Table 1) [34-35]. Families affected by these X chromosome deletions reveal progressive cone dystrophy and unusual cases with progressive macular atrophy in families with blue cone monochromacy (Table 1) [34-35]. The uniqueness of the X chromosome is addressed as not to its loci that harbor genetic changes linked to AMD (Table 1) but also a strong link to epigenetic mechanisms that may influence the genetic component in AMD (Figure 1).
Table 1.
X chromosome linked Retinopathies
| Location of chromosome | Affected protein, diseases and comments | Ref. |
|---|---|---|
| Xp22.2 | Jobert syndrome; X-linked retinitis pigmentosa, severe; genomic next-generation sequencing also uncovered a deep intronic mutation in a family with severe X-linked RP (the RP23 locus) | [18] |
| Xp21.33 | AMD and premature ovarian failure, near the DIAPH2 gene, which is known to cause premature ovarian failure (POF) in females | [3] |
| Xp22.13 | Retinoschisis; protein: retinoschisin expression is limited to photoreceptors but protein is secreted into the inner retina | [19] |
| Xp21-q21 | Retinitis pigmentosa with mental retardation | [20] |
| Xp21.3-p21.2/ Xp11.4 | X-linked retinitis pigmentosa retinitis pigmentosa GTPase regulator |
[21- 22] |
| Xp21.2-p21.1 | Oregon eye disease, candidate gene; exons 20-28 involved in retinal disease | [23- 24] |
| Xp11.4 | X-linked congenital stationary night blindness; protein: nyctalopin | [25- 26] |
| Xp11.3-p11.23 | retinal dysplasia, primary linked to the Norrie disease | [27] |
| Xp11.23 | X-linked progressive cone-rod dystrophy; protein: L-type voltage-gated calcium channel alpha-1 subunit | [28] |
| Xp11.23 | protein: retinitis pigmentosa 2 (X-linked) | [29] |
| Xq21.1 | Retinitis pigmentosa with myopathy; protein: phosphoglycerate kinase | [30] |
| Xq22.1 | optic atrophy, protein: inner mitochondrial membrane translocase 8 homolog A., protein involved in transport of metabolites into mitochondria | [31] |
| Xq26-q27 | X-linked retinitis pigmentosa | [32] |
| Xq27 | X-linked progressive cone dystrophy, genetic heterogeneity underlying this disease entity | [33] |
| Xq28-qter | X-linked retinitis pigmentosa | [34] |
| Xq28/Xq28 | Rare macular dystrophy in blue and red cone monochromacy with loss of locus control element; protein: green cone opsin and red cone opsin | [35] |
* X chromosome ideogram based on G-bands with approximate location of the centromere region
Figure 1.
AMD is shown to be a consequence of a complex process of intertwining genetic, epigenetic and environmental factors with aging
Epigenetics of AMD, relation to X chromosome?
A number of retinopathy genes have been identified and characterized (Table 1) and also recent GWAS analysis has broadened our knowledge of the complexity of the disease [36]. Using GWAS as stated, recently 5 SNIPs are found related to susceptibility to AMD with a slight gender preference [3]. However, for many diseases, including AMD, the variation in phenotype with a single genotype, individual susceptibility to disease, different findings in monozygotic twins, polygenic pleitropy, its age-related onset cannot be explained only by acquiring mutations in genes or chromosome aberrations alone [37]. There must be another layer of information (Figure 1). This missing link could be epigenetic factors [37-38]. A vast spectrum of epigenetic changes has been described. The most common epigenetic variations involve DNA methylation, various modifications of histones, chromatin remodeling, microRNA (miRNA) and small non-coding RNA expression [37-38]. Epigenetics are involved in gene expression in eye development [38].
Epigenetic mechanisms influence gene expression and function without modification of the base sequence of DNA and may be reversible, heritable, and influenced by the environment [38-39]. Epigenetics are intertwined with environmental factors such as nutrition, smoking, pollution and may express genes that are not normally triggered, therefore increasing disease susceptibility, phenotypic variation and age related progression of many common diseases including AMD, glaucoma, Alzheimer’s disease [39]. Lin et al [40] revealed that inflammation that is associated with glycation end products (AGEs) stimulates inflammatory genes in RPE cells in vitro leading to the conclusion that there is not only a complex interplay of environmental factors with our genes but we must account our epigenome to the overall picture of AMD (Figure 1).
A good example is found in twin studies. Seddon et al reported a difference between two twins [41]. One twin has been found to have a large drusen and pigmentation area accompanied with an advanced stage of AMD and these findings where related to heavy smoking. The other twin had smaller drusen size and area, and less pigmented. In his nutrition he tended to have higher dietary vitamin D or methionine intake. These findings suggest factors that are associated with epigenetic mechanisms are involved in the etiology of AMD, in addition to genetic susceptibility [40-42]. These epigenetic changes may be age-related and cell or tissue specific. They may also persist throughout the lifetime of an individual. An understanding of the role of epigenetics is important to the success of the stem cell-based therapies [42-44]. Our hypothesis is that the X chromosome has a more important role than it is noted today, in an epigenetic way. By the notion that the same genes that are responsible for genetic inheritance for AMD are also stimulated by an appropriate environmental factor that relates to AGEs and that inflammation is a key factor to AMD susceptibility may show a mechanistic pathway of how genes on the X chromosome may be influenced by alterations of X chromosome inactivation patterns [40,43-44].
HYPOTHESIS
We postulate a hypothesis of an epigenetic influence on the inactivation patterns of chromosome X in the pathogenesis of AMD. These changes of the inactivation patterns are related to skewing. Skewing by definition is a non-random X-inactivation process.
Evaluation and Discussion of the Hypothesis:
Instability in X chromosome inactivation patterns: X chromosome skewing
It has been hypothesized by Lyon in 1961 [45] that one the pair of X chromosomes in women is always inactivated in early embryonic stage. It is quite clear that; inactivation of the X chromosome is a complex epigenetic process. This mechanism keeps one individual transcriptional active chromosome per cell. In an YXX embryo the active chromosome is always the mother’s chromosome where the father is always inactivated. By the time of implementation of the egg, inactivation is erased and re-instated on the basis of randomness in the embryo, except for the germinate line where both X chromosomes are inactivated and in the placenta where only the mother’s X chromosome is expressed. Therefore, X chromosome inactivation is a random process and it is stably inherited through cell cycling which means women universally differ as to which chromosome is inactivated. Skewed X chromosome inactivation (XCI) is a marked deviation from a 50:50 ratio and is arbitrary defined, often as preferential inactivation of either maternally or paternally inherited X chromosome in 75- 80% or more of cells [46].
Skewed X inactivation of one the X chromosomes can indicate that there exists some mutations on genes on the inactive X chromosome. So, here on the X chromosome recessively or dominant inheritance is relative because heterozygous women can express a phenotype which can be compared to women’s phenotypes as a result of X chromosome inactivation [46]. Inactive X chromosome acquires a number of features of heterochromatin such as hypermetylation, hyper condensation, late replication pattern, depletion of acetylated histons [46-47]. These characteristics enables identification of the inactive X chromosome on the cytogenetic level (late replication pattern analysis, analysis of Barr body) and molecular level most analyzed by using methylation patterns [47,48]. This difference in the sensitivity to methylation can be used to analyze non-random inactivation processes in diseases that are X chromosome linked, determination of tumor clonality and iPSC adaptability, i.e., iPSC cells show that skewing is not random. Initially balanced populations consistently skewed toward a “dominant subpopulation,” expressing genes from a dominant X allele [43-44]. These cells proved to be more efficient in reprogramming, more adaptable, than the non-dominant populations. These findings indicate that differences in X-linked-associated gene function and/or expression levels might influence a cell’s ability to deal with various environmental stresses, such as DNA damage, and/or affect its replicative life span.
A skewed view of X chromosome inactivation in AMD
A recent new study of the involvement of the X chromosome in AMD has been suggested by Jiang et al [3] using a simple test for haplotype analysis of the X chromosome. This test applies haplotype-sharing (HS) statistics with sliding windows for males and females separately, which are then combined to a single HS test for the X chromosome. It should be noted that the haploid test is more powerful than single marker analysis [36]. The HS test was applied to genome wide association study GWAS of the National Eye Institute: Age Relate Eye Study NEI AREDS using 1804 SNPs [3]. What are interesting issues in this study are the results that have connected premature ovarian failure (POF) with AMD. POF is known to have an alteration of inactivation process of the X chromosome (skewing). Previous GWAS study [7] analyzed 100000 SNPs detected associations. Moreover, using the same subset of SNPs, Zheng et al. [36] conducted a single marker analysis on 1804 SNPs. Jiang et al [3] used a slight different strategy for analysis of the X chromosome in GWAS. First they used single maker analysis to rank SNPs on the X chromosome and the top ranked have been selected for haplotype analysis. This haplotype analysis from the GWAS studies confirmed risk associations for AMD as former results using single markers. Moreover, a chromosomal region consisting of five SNIPs has been associated to AMD [36]. The new research has found a disease preventive haplotype (ATGAC) in this region of SNIPs. These five SNPs are covered by the gene DIAPH2, which is known to cause premature ovarian failure (POF) in females. To date no relation between POF and AMD has been reported, although some relations have been noticed between AMD and POF [49-50]. Even though, Bretheric et al [51] by using FISH and PCR didn’t find any potential regions of DNA addition or deletion in the X chromosome, he still suggests that X-chromosome abnormalities undetectable by the arrays, or reduced follicular pool due to an early trisomic rescue event, may explain the skewed XCI observed in POF patients with primary amenorrhea. With the work of Baronchelli et al [52] these results suggest that a strong genetic factor in the etiology of POFis emphasized by the high percentage of familial cases in which X chromosome abnormalities account for 10% of chromosomal aberrations and that these alterations are possibly accompanied by epigenetic changes to the X chromosome inactivation patterns, or X chromosome skewing. Better said, numerous cases of POF in women with X-chromosome deletions or translocations have been reported; thus, it is possible that smaller rearrangements undetectable by conventional cytogenetics may contribute to cells with inactivation of the normal X chromosome and may be selected against, causing skewed X-chromosome inactivation (XCI) in AMD.
Aging and skewing
X chromosome skewing is affected by the aging process. This age-related, acquired XCI skewing can lead to late-onset disease in individuals, as has been reported for X-linked sideroblastic anemia [53] however if age-related, acquired XCI skewing occurs in tissues other than blood, then late-onset symptoms might be a concern for additional X-linked disorders which includes a number of other diagnosis such as premature ovarian failure, scleroderma (an autoimmune disorder), spontaneous abortions, a number of cancers, most often breast cancer [54]. In some severe X-linked disorders, post-inactivation selection takes place against the X chromosome carrying the mutant allele, leading to a completely skewed X-inactivation pattern and may indicate an effect of X-linked genes on the development of these conditions [46,55-56]. What is interesting except X chromosome skewing is that no causative X-linked locus has yet been identified in such associations, so causes of XCI skewing in addition to selection needs to be considered. One view supports the model of increased skewing with age as a consequence of hematopoietic stem cell senescence [57]. The second view suggests age-related skewing is a combination of stochastic and genetic events [58].
All this suggests that the process of X inactivation and the resultant degree of skewing is clearly important for the expression of diseases with a strong genetic background, such as AMD.
CONCLUSION
The complexity of disease as in AMD shows that no one factor can be promoted to the causality of the disease, but instead we have to relate to the interplay of epigenetic and genetic processes intertwined by environmental factors as seen in Figure 1. The X chromosome, even though not solely the only intrinsic factor in the genetic sense to contribute to AMD, but its X-linked genes on the two X chromosomes summons such a genetic variation pool in which single nucleotide polymorphisms(SNPs) and deletions are very common and may affect various cellular functions [59]. For example, polymorphisms in promoter/enhancer sequences might influence gene regulation, whereas other SNPs may affect RNA splicing or protein function. The findings of five SNPs in in the DIAPH 2 gene susceptible to AMD [3] which is also the gene responsible of form of POF. POF is known to promote X chromosome skewing [52,60-61]. Most of the X-linked genes are not involved in sex determination but in various other processes such as free radical scavenging, housekeeping, apoptosis, cell cycle regulation, tumor suppression [43-44]. All these processes may have another level of activity, good or bad, through the process of X chromosome inactivation [62]. Carrel et al [63] observed that 15 % of linked genes escape inactivation. Escapees are present on active and inactive X chromosomes. This shows an unsuspected degree of expression heterogeneity among females. X chromosome shows also a heritable variation in X-chromosome inactivation pattern in normal females [64]. There is genetic effect on the imprinting of X-chromosome inactivation in humans. Male offspring of females with skewed X-inactivation patterns were three times more likely to inherit alleles at loci that were located on the inactive X chromosome than the active X chromosome [17,64-65] .To broaden this notion, Plenge et al [66] explored skewed X chromosome inactivation and X linked mental retardation disorders (XLMR) and found that mutation carriers demonstrate a strong association with skewed X inactivation. The XLMR mutations are present on the preferentially inactive X chromosome in all 20 informative female subjects from these families, indicating that skewing is due to selection against those cells in which the XLMR mutation is on the active X chromosome [66].
To our view, the hypothesis of X chromosome instability in AMD seen as skewing may be broadened by the view that we may have a detrimental effect to DNA repair mechanisms in aged subjects by processes of skewing and aging. Aging is known to decrease repair of DNA damage in the nuclei and in mitochondria [67-68]. So skewing and aging may determine the amount of accumulated cellular DNA damage. In correspondence to Figure 1, DNA damage depends also on environmental and/or genetic conditions. These conditions help or undermine the cells ability to respond to, and repair damaged DNA and to repair telomere shortening. Pomp et al. [44] reported that skewing in a heterogeneous population of iPSC cells can be alleviated by ectopic expression of telomerase, and that this process profoundly cooperates in DNA repair. Another more controversial theme is transgenerational epigenetic inheritance [69-71]. That is, the environment can stably influence the establishment of the epigenome. Together with the fact that there is X inactivation inheritance pattern suggests that an environmental event in one generation could affect the phenotype in subsequent generations. Whether there is any merit to these assumptions that X chromosome skewing maybe also transgenerational inherited and contribute to the cause of the complex disease such as AMD is an important question to be answered in future research.
DISCLOSURE
Conflicts of Interest: None declared.
ACKNOWLEDGMENT
This work is supported by the Ministry of Education and Science of the Republic of Serbia (Grant 173034).
References
- 1.Brown CJ. Role of the X chromosome in cancer. J Natl Cancer Inst. 1996 Apr;88(8):480–2. doi: 10.1093/jnci/88.8.480. PMID: 8606372. [DOI] [PubMed] [Google Scholar]
- 2.Rudnicka AR, Jarrar Z, Wormald R, Cook DG, Fletcher A, Owen CG. Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology. 2012 Mar;119(3):571–80. doi: 10.1016/j.ophtha.2011.09.027. PMID: 22176800. [DOI] [PubMed] [Google Scholar]
- 3.Jiang R, Dong J, Joo J, Geller NL, Zheng G. Simple strategies for haplotype analysis of the X chromosome with application to age-related macular degeneration. Eur J Hum Genet. 2011 Jul;19(7):801–6. doi: 10.1038/ejhg.2011.35. PMID: 21386871. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Ayyagari R, Demirci FY, Liu J, Bingham EL, Stringham H, Kakuk LE, Boehnke M, Gorin MB, Richards JE, Sieving PA. X-linked recessive atrophic macular degeneration from RPGR mutation. Genomics. 2002 Aug;80(2):166–71. doi: 10.1006/geno.2002.6815. PMID: 12160730. [DOI] [PubMed] [Google Scholar]
- 5.Tan JS, Wang JJ, Flood V, Rochtchina E, Smith W, Mitchell P. Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology. 2008 Feb;115(2):334–41. doi: 10.1016/j.ophtha.2007.03.083. Epub 2007 Jul 30. [DOI] [PubMed] [Google Scholar]
- 6.Gehrs KM, Anderson DH, Johnson LV, Hageman GS. Age-related macular degeneration--emerging pathogenetic and therapeutic concepts. Ann Med. 2006;38(7):450–71. doi: 10.1080/07853890600946724. Review. PMID: 17101537. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Klein R, Klein BE, Knudtson MD, Meuer SM, Swift M, Gangnon RE. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology. 2007 Feb;114(2):253–62. doi: 10.1016/j.ophtha.2006.10.040. PMID: 17270675. [DOI] [PubMed] [Google Scholar]
- 8.Ohno-Matsui K. Parallel findings in age-related macular degeneration and Alzheimer's disease. Prog Retin Eye Res. 2011 Jul;30(4):217–38. doi: 10.1016/j.preteyeres.2011.02.004. doi: 10.1016/j.preteyeres.2011.02.004. Epub 2011 Mar 25. Review. PMID: 21440663. [DOI] [PubMed] [Google Scholar]
- 9.Khandhadia S, Lotery A. Oxidation and age-related macular degeneration: insights from molecular biology. Expert Rev Mol Med. 2010 Oct;12:e34. doi: 10.1017/S146239941000164X. doi:10.1017/S146239941000164X. PMID: 20959033. [DOI] [PubMed] [Google Scholar]
- 10.Hollyfield JG, Bonilha VL, Rayborn ME, Yang X, Shadrach KG, Lu L, Ufret RL, Salomon RG, Perez VL. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med. 2008 Feb;14(2):194–8. doi: 10.1038/nm1709. PMID: 18223656. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Mullins RF, Russell SR, Anderson DH, Hageman GS. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 2000 May;14(7):835–46. PMID: 10783137. [PubMed] [Google Scholar]
- 12.Lueck K, Hennig M, Lommatzsch A, Pauleikhoff D, Wasmuth S. Complement and UV-irradiated photoreceptor outer segments increase the cytokine secretion by retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2012 Mar;53(3):1406–13. doi: 10.1167/iovs.11-8889. PMID: 22323489. [DOI] [PubMed] [Google Scholar]
- 13.Krishnadev N, Meleth AD, Chew EY. Nutritional supplements for age-related macular degeneration. Curr Opin Ophthalmol. 2010 May;21(3):184–9. doi: 10.1097/ICU.0b013e32833866ee. PMID: 20216418. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Wang L, Clark ME, Crossman DK, Kojima K, Messinger JD, Mobley JA, Curcio CA. Abundant lipid and protein components of drusen. PLoS One. 2010 Apr 23;5(4):e10329. doi: 10.1371/journal.pone.0010329. PMID: 20428236. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Tuppo EE, Arias HR. The role of inflammation in Alzheimer's disease. Int J Biochem Cell Biol. 2005 Feb;37(2):289–305. doi: 10.1016/j.biocel.2004.07.009. PMID: 15474976. [DOI] [PubMed] [Google Scholar]
- 16.Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, Zlateva G, Buggage R, Pleil A, Mitchell P. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol. 2010 Dec ;10:31. doi: 10.1186/1471-2415-10-31. PMID: 21144031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Bocklandt S, Horvath S, Vilain E, Hamer DH. Extreme skewing of X chromosome inactivation in mothers of homosexual men. Hum Genet. 2006 Feb;118(6):691–4. doi: 10.1007/s00439-005-0119-4. PMID: 16369763. [DOI] [PubMed] [Google Scholar]
- 18.Webb TR, Parfitt DA, Gardner JC, Martinez A, Bevilacqua D, Davidson AE, Zito I, Thiselton DL, Ressa JH, Apergi M, Schwarz N, Kanuga N, Michaelides M, Cheetham ME, Gorin MB, Hardcastle AJ. Deep intronic mutation in OFD1, identified by targeted genomic next-generation sequencing, causes a severe form of X-linked retinitis pigmentosa (RP23) Hum Mol Genet. 2012 Aug;21(16):3647–54. doi: 10.1093/hmg/dds194. PMID: 22619378. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Functional implications of the spectrum of mutations found in 234 cases with X-linked juvenile retinoschisis. The Retinoschisis Consortium. Hum Mol Genet. 1998 Jul;7(7):1185–92. doi: 10.1093/hmg/7.7.1185. PMID: 9618178. [DOI] [PubMed] [Google Scholar]
- 20.Aldred MA, Dry KL, Knight-Jones EB, Hardwick LJ, Teague PW, Lester DH, Brown J, Spowart G, Carothers AD, Raeburn JA, et al. Genetic analysis of a kindred with X-linked mental handicap and retinitis pigmentosa. Am J Hum Genet. 1994 Nov;55(5):916–22. PMID: 7977353. [PMC free article] [PubMed] [Google Scholar]
- 21.Breuer DK, Yashar BM, Filippova E, Hiriyanna S, Lyons RH, Mears AJ, Asaye B, Acar C, Vervoort R, Wright AF, Musarella MA, Wheeler P, MacDonald I, Iannaccone A, Birch D, Hoffman DR, Fishman GA, Heckenlively JR, Jacobson SG, Sieving PA, Swaroop A. A comprehensive mutation analysis of RP2 and RPGR in a North American cohort of families with X-linked retinitis pigmentosa. Am J Hum Genet. 2002 Jun;70(6):1545–54. doi: 10.1086/340848. PMID: 11992260. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Musarella MA, Anson-Cartwright L, Leal SM, Gilbert LD, Worton RG, Fishman GA, Ott J. Multipoint linkage analysis and heterogeneity testing in 20 X-linked retinitis pigmentosa families. Genomics. 1990 Oct;8(2):286–96. doi: 10.1016/0888-7543(90)90284-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.D'Souza VN, Nguyen TM, Morris GE, Karges W, Pillers DA, Ray PN. A novel dystrophin isoform is required for normal retinal electrophysiology. Hum Mol Genet. 1995 May;4(5):837–42. doi: 10.1093/hmg/4.5.837. PMID: 7633443. [DOI] [PubMed] [Google Scholar]
- 24.Assink JJ, Tijmes NT, ten Brink JB, Oostra RJ, Riemslag FC, de Jong PT, Bergen AA. A gene for X-linked optic atrophy is closely linked to the Xp11.4-Xp11.2 region of the X chromosome. Am J Hum Genet. 1997 Oct;61(4):934–9. doi: 10.1086/514884. PMID: 9382106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Pusch CM, Zeitz C, Brandau O, Pesch K, Achatz H, Feil S, Scharfe C, Maurer J, Jacobi FK, Pinckers A, Andreasson S, Hardcastle A, Wissinger B, Berger W, Meindl A. The complete form of X-linked congenital stationary night blindness is caused by mutations in a gene encoding a leucine-rich repeat protein. Nat Genet. 2000 Nov;26(3):324–7. doi: 10.1038/81627. PMID: 11062472. [DOI] [PubMed] [Google Scholar]
- 26.Zhang Q, Acland GM, Wu WX, Johnson JL, Pearce-Kelling S, Tulloch B, Vervoort R, Wright AF, Aguirre GD. Different RPGR exon ORF15 mutations in Canids provide insights into photoreceptor cell degeneration. Hum Mol Genet. 2002 May 1;11(9):993–1003. doi: 10.1093/hmg/11.9.993. PMID: 11978759. [DOI] [PubMed] [Google Scholar]
- 27.Ravia Y, Braier-Goldstein O, Bat-Miriam KM, Erlich S, Barkai G, Goldman B. X-linked recessive primary retinal dysplasia is linked to the Norrie disease locus. Hum Mol Genet. 1993 Aug;2(8):1295–7. doi: 10.1093/hmg/2.8.1295. PMID: 8401512. [DOI] [PubMed] [Google Scholar]
- 28.Nakamura M, Ito S, Piao CH, Terasaki H, Miyake Y. Retinal and optic disc atrophy associated with a CACNA1F mutation in a Japanese family. Arch Ophthalmol. 2003 Jul;121(7):1028–33. doi: 10.1001/archopht.121.7.1028. PMID: 12860808. [DOI] [PubMed] [Google Scholar]
- 29.Schwahn U, Lenzner S, Dong J, Feil S, Hinzmann B, van Duijnhoven G, Kirschner R, Hemberger M, Bergen AA, Rosenberg T, Pinckers AJ, Fundele R, Rosenthal A, Cremers FP, Ropers HH, Berger W. Positional cloning of the gene for X-linked retinitis pigmentosa 2. Nat Genet. 1998 Aug;19(4):327–32. doi: 10.1038/1214. PMID: 9697692. [DOI] [PubMed] [Google Scholar]
- 30.Tonin P, Shanske S, Miranda AF, Brownell AK, Wyse JP, Tsujino S, DiMauro S. Phosphoglycerate kinase deficiency: biochemical and molecular genetic studies in a new myopathic variant (PGK Alberta) Neurology. 1993 Feb;43(2):387–91. doi: 10.1212/wnl.43.2.387. [DOI] [PubMed] [Google Scholar]
- 31.Koehler CM, Leuenberger D, Merchant S, Renold A, Junne T, Schatz G. Human deafness dystonia syndrome is a mitochondrial disease. Proc Natl Acad Sci U S A. 1999 Mar;96(5):2141–6. doi: 10.1073/pnas.96.5.2141. PMID: 10051608. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Gieser L, Fujita R, Göring HH, Ott J, Hoffman DR, Cideciyan AV, Birch DG, Jacobson SG, Swaroop A. A novel locus (RP24) for X-linked retinitis pigmentosa maps to Xq26-27. Am J Hum Genet. 1998 Nov;63(5):1439–47. doi: 10.1086/302121. PMID: 9792872. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Bergen AA, Pinckers AJ. Localization of a novel X-linked progressive cone dystrophy gene to Xq27: evidence for genetic heterogeneity. Am J Hum Genet. 1997 Jun;60(6):1468–73. doi: 10.1086/515458. Erratum in: Am J Hum Genet 1997 Aug;61(2):471. PMID: 9199568. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Melamud A, Shen GQ, Chung D, Xi Q, Simpson E, Li L, Peachey NS, Zegarra H, Hagstrom SA, Wang QK, Traboulsi EI. Mapping a new genetic locus for X linked retinitis pigmentosa to Xq28. J Med Genet. 2006 Jun;43(6):e27. doi: 10.1136/jmg.2005.031518. PMID: 16740911. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Ayyagari R, Kakuk LE, Coats CL, Bingham EL, Toda Y, Felius J, Sieving PA. Bilateral macular atrophy in blue cone monochromacy (BCM) with loss of the locus control region (LCR) and part of the red pigment gene. Mol Vis. 1999 Jul;5:13. PMID: 10427103. [PubMed] [Google Scholar]
- 36.Zheng G, Joo J, Zhang C, Geller NL. Testing association for markers on the X chromosome. Genet Epidemiol. 2007 Dec;31(8):834–43. doi: 10.1002/gepi.20244. PMID: 17549761. [DOI] [PubMed] [Google Scholar]
- 37.Petronis A. Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature. 2010 Jun ;465(7299):721–7. doi: 10.1038/nature09230. PMID: 20535201. [DOI] [PubMed] [Google Scholar]
- 38.He S, Li X, Chan N, Hinton DR. Review: Epigenetic mechanisms in ocular disease. Mol Vis. 2013;19:665–74. PMID: 23559860. [PMC free article] [PubMed] [Google Scholar]
- 39.Adwan L, Zawia NH. Epigenetics: A novel therapeutic approach for the treatment of Alzheimer's disease. Pharmacol Ther. Apr; doi: 10.1016/j.pharmthera.2013.03.010. PMID: 23562602. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Lin T, Walker GB, Kurji K, Fang E, Law G, Prasad SS, Kojic L, Cao S, White V, Cui JZ, Matsubara JA. Parainflammation associated with advanced glycation endproduct stimulation of RPE in vitro: Implications for age-related degenerative diseases of the eye. Cytokine. Apr; doi: 10.1016/j.cyto.2013.03.027. PMID: 23601964. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Seddon JM, Reynolds R, Shah HR, Rosner B. Smoking, dietary betaine, methionine, and vitamin D in monozygotic twins with discordant macular degeneration: epigenetic implications. Ophthalmology. 2011 Jul;118(7):1386–94. doi: 10.1016/j.ophtha.2010.12.020. PMID: 21620475. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR, Hon G, Antosiewicz-Bourget J, O'Malley R, Castanon R, Klugman S, Downes M, Yu R, Stewart R, Ren B, Thomson JA, Evans RM, Ecker JR. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature. 2011 Mar ;471(7336):68–73. doi: 10.1038/nature09798. PMID:21289626. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Pomp O, Dreesen O, Colman A. The "X factor" in cellular reprogramming and proliferation. Cell Cycle. 2011 Dec ;10(23):3992–3. doi: 10.4161/cc.10.23.18253. PMID: 22101271. [DOI] [PubMed] [Google Scholar]
- 44.Pomp O, Dreesen O, Leong DF, Meller-Pomp O, Tan TT, Zhou F, Colman A. Unexpected X chromosome skewing during culture and reprogramming of human somatic cells can be alleviated by exogenous telomerase. Cell Stem Cell. 2011 Aug ;9(2):156–65. doi: 10.1016/j.stem.2011.06.004. PMID: 21816366. [DOI] [PubMed] [Google Scholar]
- 45.LYON MF. Gene action in the X-chromosome of the mouse (Mus musculus L.) Nature. 1961 Apr;190:327–3. doi: 10.1038/190372a0. PMID: 13764598. [DOI] [PubMed] [Google Scholar]
- 46.Orstavik KH. X chromosome inactivation in clinical practice. Hum Genet. 2009 Sep;126(3):363–73. doi: 10.1007/s00439-009-0670-5. PMID: 19396465. [DOI] [PubMed] [Google Scholar]
- 47.Corbel C, Diabangouaya P, Gendrel AV, Chow JC, Heard E. Unusual chromatin status and organization of the inactive X chromosome in murine trophoblast giant cells. Development. 2013 Feb;140(4):861–72. doi: 10.1242/dev.087429. PMID:23362347. [DOI] [PubMed] [Google Scholar]
- 48.Sharp AJ, Stathaki E, Migliavacca E, Brahmachary M, Montgomery SB, Dupre Y, Antonarakis SE. DNA methylation profiles of human active and inactive X chromosomes. Genome Res. 2011 Oct;21(10):1592–600. doi: 10.1101/gr.112680.110. PMID: 21862626. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Smith JA, Vitale S, Reed GF, Grieshaber SA, Goodman LA, Vanderhoof VH, Calis KA, Nelson LM. Dry eye signs and symptoms in women with premature ovarian failure. Arch Ophthalmol. 2004 Feb;122(2):151–6. doi: 10.1001/archopht.122.2.151. PMID: 14769589. [DOI] [PubMed] [Google Scholar]
- 50.Sato K, Uehara S, Hashiyada M, Nabeshima H, Sugawara J, Terada Y, Yaegashi N, Okamura K. Genetic significance of skewed X-chromosome inactivation in premature ovarian failure. Am J Med Genet A. 2004 Oct 15;130A(3):240–4. doi: 10.1002/ajmg.a.30256. PMID: 15378546. [DOI] [PubMed] [Google Scholar]
- 51.Bretherick KL, Metzger DL, Chanoine JP, Panagiotopoulos C, Watson SK, Lam WL, Fluker MR, Brown CJ, Robinson WP. Skewed X-chromosome inactivation is associated with primary but not secondary ovarian failure. Am J Med Genet A. 2007 May 1;143A(9):945–51. doi: 10.1002/ajmg.a.31679. PMID: 17431892. [DOI] [PubMed] [Google Scholar]
- 52.Baronchelli S, Villa N, Redaelli S, Lissoni S, Saccheri F, Panzeri E, Conconi D, Bentivegna A, Crosti F, Sala E, Bertola F, Marozzi A, Pedicini A, Ventruto M, Police MA, Dalprà L. Investigating the role of X chromosome breakpoints in premature ovarian failure. Mol Cytogenet. 2012 Jul ;5(1):32. doi: 10.1186/1755-8166-5-32. PMID: 22794123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Cazzola M, May A, Bergamaschi G, Cerani P, Rosti V, Bishop DF. Familial-skewed X-chromosome inactivation as a predisposing factor for late-onset X-linked sideroblastic anemia in carrier females. Blood. 2000 Dec ;96(13):4363–5. PMID: 11110715. [PubMed] [Google Scholar]
- 54.Minks J, Robinson WP, Brown CJ. A skewed view of X chromosome inactivation. J Clin Invest. 2008 Jan;118(1):20–3. doi: 10.1172/JCI34470. PMID: 18097476. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Ørstavik KH. Skewed X inactivation in healthy individuals and in different diseases. Acta Paediatr Suppl. 2006 Apr;95(451):24–9. doi: 10.1111/j.1651-2227.2006.tb02385.x. Review. PMID: 16720461. [DOI] [PubMed] [Google Scholar]
- 56.Gentilini D, Castaldi D, Mari D, Monti D, Franceschi C, Di Blasio AM, Vitale G. Age-dependent skewing of X chromosome inactivation appears delayed in centenarians' offspring. Is there a role for allelic imbalance in healthy aging and longevity? . Aging Cell. 2012 Apr;11(2):277–83. doi: 10.1111/j.1474-9726.2012.00790.x. PMID: 22292741. [DOI] [PubMed] [Google Scholar]
- 57.Hatakeyama C, Anderson CL, Beever CL, Peñaherrera MS, Brown CJ, Robinson WP. The dynamics of X-inactivation skewing as women age. Clin Genet. 2004 Oct;66(4):327–32. doi: 10.1111/j.1399-0004.2004.00310.x. PMID: 15355435. [DOI] [PubMed] [Google Scholar]
- 58.Kristiansen M, Knudsen GP, Bathum L, Naumova AK, Sørensen TI, Brix TH, Svendsen AJ, Christensen K, Kyvik KO, Ørstavik KH. Twin study of genetic and aging effects on X chromosome inactivation. Eur J Hum Genet. 2005 May;13(5):599–606. doi: 10.1038/sj.ejhg.5201398. [DOI] [PubMed] [Google Scholar]
- 59.Myking S, Boyd HA, Myhre R, Feenstra B, Jugessur A, Devold Pay AS, Ostensen IH, Morken NH, Busch T, Ryckman KK, Geller F, Magnus P, Gjessing HK, Melbye M, Jacobsson B, Murray JC. X-Chromosomal Maternal and Fetal SNPs and the Risk of Spontaneous Preterm Delivery in a Danish/Norwegian Genome-Wide Association Study. PLoS One. 2013 Apr;8(4):e61781. doi: 10.1371/journal.pone.0061781. PMID: 23613933. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Yoon SH, Choi YM, Hong MA, Kang BM, Kim JJ, Min EG, Kim JG, Moon SY. X chromosome inactivation patterns in patients with idiopathic premature ovarian failure. Hum Reprod. 2008 Mar;23(3):688–92. doi: 10.1093/humrep/dem415. PMID: 18182395. [DOI] [PubMed] [Google Scholar]
- 61.Bione S, Sala C, Manzini C, Arrigo G, Zuffardi O, Banfi S, Borsani G, Jonveaux P, Philippe C, Zuccotti M, Ballabio A, Toniolo D. A human homologue of the Drosophila melanogaster diaphanous gene is disrupted in a patient with premature ovarian failure: evidence for conserved function in oogenesis and implications for human sterility. Am J Hum Genet. 1998 Mar;62(3):533–41. doi: 10.1086/301761. PMID: 9497258. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Wolff DJ, Schwartz S, Carrel L. Molecular determination of X inactivation pattern correlates with phenotype in women with a structurally abnormal X chromosome. Genet Med. 2000 Mar-Apr;2(2):136–41. doi: 10.1097/00125817-200003000-00004. PMID: 11397327. [DOI] [PubMed] [Google Scholar]
- 63.Carrel L, Willard HF. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature. 2005 Mar;434(7031):400–4. doi: 10.1038/nature03479. PMID: 15772666. [DOI] [PubMed] [Google Scholar]
- 64.Naumova AK, Olien L, Bird LM, Slamka C, Fonseca M, Verner AE, Wang M, Leppert M, Morgan K, Sapienza C. Transmission-ratio distortion of X chromosomes among male offspring of females with skewed X-inactivation. Dev Genet. 1995;17(3):198–205. doi: 10.1002/dvg.1020170304. PMID: 8565326. [DOI] [PubMed] [Google Scholar]
- 65.Ngun TC, Ghahramani N, Sánchez FJ, Bocklandt S, Vilain E. The genetics of sex differences in brain and behavior. Front Neuroendocrinol. 2011 Apr;32(2):227–46. doi: 10.1016/j.yfrne.2010.10.001. PMID:20951723. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Plenge RM, Stevenson RA, Lubs HA, Schwartz CE, Willard HF. Skewed X-chromosome inactivation is a common feature of X-linked mental retardation disorders. Am J Hum Genet. 2002 Jul;71(1):168–73. doi: 10.1086/341123. PMID: 12068376. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Salminen A, Ojala J, Kaarniranta K, Kauppinen A. Mitochondrial dysfunction and oxidative stress activate inflammasomes: impact on the aging process and age-related diseases. Cell Mol Life Sci. 2012 Sep;69(18):2999–3013. doi: 10.1007/s00018-012-0962-0. PMID: 22446749. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Bratic I, Trifunovic A. Mitochondrial energy metabolism and ageing. Biochim Biophys Acta. 2010 Jun-Jul;1797(6-7):961–7. doi: 10.1016/j.bbabio.2010.01.004. PMID: 20064485. [DOI] [PubMed] [Google Scholar]
- 69.Pembrey ME, Bygren LO, Kaati G, Edvinsson S, Northstone K, Sjöström M, Golding J. ALSPAC Study Team. Sex-specific, male-line transgenerational responses i humans. Eur J Hum Genet. 2006 Feb;14(2):159–66. doi: 10.1038/sj.ejhg.5201538. PMID: 16391557. [DOI] [PubMed] [Google Scholar]
- 70.Daxinger L, Whitelaw E. Understanding transgenerational epigenetic inheritance via the gametes in mammals. Nat Rev Genet. 2012 Jan;13(3):153–62. doi: 10.1038/nrg3188. PMID: 22290458. [DOI] [PubMed] [Google Scholar]
- 71.Daxinger L, Whitelaw E. Transgenerational epigenetic inheritance: more questions than answers. Genome Res. 2010 Dec;20(12):1623–8. doi: 10.1101/gr.106138.110. PMID: 21041414. [DOI] [PMC free article] [PubMed] [Google Scholar]

